Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALOXONE vs NARATRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALOXONE vs NARATRIPTAN: Safety Overview

Metric NALOXONE NARATRIPTAN
Total FAERS Reports 2,859 526
Deaths Reported 779 9
Death Rate 27.2% 1.7%
Hospitalizations 1,033 102
Average Patient Age 43.8 yrs 49.2 yrs
% Female Patients 44.6% 90.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 22, 2011
Manufacturer Meitheal Pharmaceuticals Inc. Hikma Pharmaceuticals USA Inc.
Route INTRAMUSCULAR ORAL
Marketing Status Discontinued Discontinued